In the United States, many pregnant females and women in the first year after giving birth have a perinatal and postpartum depressive disorder. Depression may have a serious impact on a mother’s health and raise the danger of preterm labor and low birth weight (Inekwe & Lee, 2022). Untreated depressive disorders can make it more likely for women to not follow their doctors’ orders, use tobacco and other drugs more frequently, make other medical disorders worse, and even result in suicide and homicide (Premji et al., 2019). The comprehensive screening for depression in pregnant patients is advised by several significant healthcare organizations.
Females of reproductive age frequently have depression conditions, which can start during pregnancies or the postpartum phase (Kariuki et al., 2021). The standards specified by the WHO to advise policy-makers on the benefits of population-based screening are satisfied by assessing prenatal and postpartum females for depressive disorders. Depression is a problem for public health because it has a detrimental effect on relationships, jobs, physical and psychological well-being, and quality of life (Guo et al., 2022; Shuffrey et al., 2022). Since depression has a wide range of indications and an unpredictable start, screening is likely to identify cases of the illness that may otherwise go undetected. It is known how the illness develops naturally, and depressive disorders are more likely to endure and get worse than to get better on their own.
Patient-acceptable screening methods and therapies are available. Most notably, compared to standard treatment, screening schemes for prenatal and postpartum females lower the relative risk of persistent depression at 3 to 5 months by 18% to 59% (Learman, 2018). The assessment of screening tests takes place against a gold standard for diagnosis. A systematic interview that will disclose all of the elements included in DSM-5 is the golden standard for identifying depression. Here, it should be noted that MDD is the main focus of depression screening instruments (Anokye et al., 2018). Nevertheless, the potential to enhance timely postpartum depression treatment and maximize family well-being through regular screening has the capacity to save costs in the dimension of the health system. However, there are discrepancies in regular screening guidelines across the board, involving the use of certain screening tools and cut-off values (Noda et al., 2022). Furthermore, there is less research addressing the rates of PPD detection and therapy after screening.
Although several groups have advocated for all pregnant and postpartum females to be screened for depression, not all societies have adopted this advice. A short study of maternity practices in inner cities found that 28% of the post-visit records had no information about the patient’s psychological health (Gisseman et al., 2021). Additionally, without a screening tool, the obstetricians in the research performed much poorer in identifying depressive symptoms. Only 13% of research participants were recognized as being at risk based only on their medical history and physical examination, but 22% of participants tested positive for depression. The provided aspects seem to add relevance to the discussion on how utilizing a postpartum depression screening tool during the perinatal period in postpartum women, compared with no screening tool, impacts the identification or diagnosis of risk.
Using JMP v13.2, statistical calculations can be carried out as was shown in similar investigations within the scope of the theme. ANOVA with a Tukey correction may be used to evaluate constant variables utilizing averages and standard variances (Gisseman et al., 2021). For non-normal datasets, the Mann-Whitney test can be applied to describe categorical variables employing median and interquartile ranges. Then, the ethical principles on which the study will be based may be formulated as follows. First, it is informed consent – participants are to be provided with comprehensive information about the research without duress. Second, it is confidentiality – no personal data can be revealed without participants’ permission. Third, it is integrity – the study should be transparent and follow the best academic practices.
References
Anokye, R., Acheampong, E., Budu-Ainooson, A., Obeng, E., & Akwasi, A. (2018). Prevalence of postpartum depression and interventions utilized for its management. Annals of General Psychiatry, 17. Web.
Gisseman, J., Fletcher, T., Schmolze, A., Cooper, D., Aden, J., & Cox-Bauer, C. (2021). Depression screening during pregnancy: Compliance and effectiveness in a military population. Military Medicine, 186, e951–e955. Web.
Guo, X., Guo, X., Wang, R., & Zhang, Y. (2022). Effects of perinatal cognitive behavioral therapy on delivery mode, fetal outcome, and postpartum depression and anxiety in women. Computational and Mathematical Methods in Medicine. Web.
Inekwe, J., & Lee, E. (2022). Perceived social support on postpartum mental health: An instrumental variable analysis. PLoS ONE, 17(5). Web.
Kariuki, E. W., Kuria, M. W., Were, F. N., & Ndetei, D. M. (2021). Effectiveness of a brief psychoeducational intervention on postnatal depression in the slums, Nairobi: a longitudinal study. Archives of Women’s Mental Health, 24(3), 503–511. Web.
Learman, L. (2018). Screening for depression in pregnancy and the postpartum period. Clinical Obstetrics & Gynecology, 61(3), 525–532.
Noda, M., Sato, Y., Suetsugu, Y., & Morokuma, S. (2022). Interoception is associated with anxiety and depression in pregnant women: A pilot study. PLoS ONE, 17(5). Web.
Premji, S., McDonald, S. W., Metcalfe, A., Faris, P., Quan, H., Tough, S., & McNeil, D. A. (2019). Examining postpartum depression screening effectiveness in well-child clinics in Alberta, Canada: A study using the all our families cohort and administrative data. Preventive Medicine Reports, 14. Web.
Shuffrey, L. C., Thomason, M. E., & Brito, N. H. (2022). Improving perinatal maternal mental health starts with addressing structural inequities. JAMA Psychiatry, 79(5), 387–388. Web.
Thomas, D. (2020). Postpartum depression. Indian Research Journal of Pharmacy and Science.